Medpace Beats Q2 Revenue Estimates todayheadline
Medpace (MEDP 54.51%), a clinical contract research organization that manages drug development for pharmaceutical and biotech clients, reported its second ...
Read moreDetailsTag: Beats
Commerce Bancshares Beats Q2 EPS by 9% todayheadline
Commerce Bancshares (CBSH 0.56%), a regional banking group known for its super-community banking model, reported results for the second quarter ...
Read moreDetails
Amazon is selling $200 Beats Solo 4 headphones for $98, their lowest price ever, during the final hours of Prime Day todayheadline
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we ...
Read moreDetails
Mexico beats U.S. 2-1 to win 10th Gold Cup title
HOUSTON — Mexico beat the United States 2-1 on Sunday night for its record 10th CONCACAF Gold Cup title, with ...
Read moreDetails
China fund beats 97% of peers by buying Pop Mart, dumping Moutai todayheadline
A 30-year-old Chinese fund manager is trouncing peers this year with a portfolio stocked with Gen Z-favored names like Pop ...
Read moreDetails
McLaren drivers clash in Canada as George Russell beats Verstappen to win F1 race
MONTREAL — George Russell won the Canadian Grand Prix with a lights-to-flag victory on a hot Sunday in this city, ...
Read moreDetails
George Russell beats Verstappen and Piastri to take pole for second straight year in Canadian GP todayheadline
Mercedes man George Russell stormed to pole position in qualifying for the Canadian Grand Prix on Saturday (June 15) for ...
Read moreDetails
French Open 2025: Novak Djokovic beats Alexander Zverev, set to face Jannik Sinner in semi-final todayheadline
Novak Djokovic beat Alexander Zverev to reach the semi-final of the French Open 2025 on Wednesday in Paris, becoming the ...
Read moreDetails
Why the MIND diet beats Mediterranean in protecting against dementia
New evidence finds that the MIND diet lives up to its name, even when it is started later in life.Middle-aged ...
Read moreDetails
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study ...
Read moreDetails
